US FDA Approved Novel Drugs for Year 2020
admin Admission Alerts Abametapir To treat head lice, Amisulpride To help prevent nausea and vomiting after surgery, and Odesivimab-ebgn To treat ebola virus, Ansuvimab-zykl To treat ebola, Atoltivimab, Belantamab mafodotin-blmf To treat multiple myeloma, Berotralstat To treat patients with hereditary angioedema, Clascoterone To treat acne, Copper Cu 64 dotatate injection To help detect certain types of neuroendocrine tumors, Decitabine and Cedazuridine To treat adult patients with myelodysplastic syndromes, Fostemsavir To treat HIV, Gallium 68 PSMA-11 For detection and localization of prostate cancer, Lonafarnib To treat rare conditions related to premature aging, Lumasiran To treat hyperoxaluria type 1, Maftivimab, Margetuximab (anti-HER2 mAb To treat HER2+ breast cancer, Naxitamab-gqgk To treat high-risk refractory or relapsed neuroblastoma, New Drugs approved in Year 2020, New Drugs approved in Year 2020 by USFDA, Nifurtimox To treat Chagas disease, Novel Drugs Approved for Year 2020, Oliceridine To manage acute pain in certain adults, Pralsetinib To treat non-small lung cancer, Relugolix To treat advanced prostate cancer, Remdesivir To treat COVID-19, Remimazolam For treatment of sedation, Rimegepant To treat migraine, Risdiplam To treat spinal muscular atrophy, Setmelanotide To treat obesity, Tafasitamab-cxix To treat relapsed or refractory diffuse large B-cell lymphoma, Tirbanibulin To treat actinic Keratosis of the face or scalp, Triheptanoin To treat molecularly long-chain fatty acid oxidation disorders, Vibegron for To treat overactive bladder, Viltolarsen To treat Duchenne muscular dystrophy Leave a comment
Find the list of Approved new drug ingredient which are approved by US FDA in year 2020 No. Active Ingredient FDA-approved use on approval date* Approval Date 1 Vibegron To treat overactive bladder 12/23/2020 2 Ansuvimab-zykl To treat ebola […]